News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sanna Bastiano
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4
| Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Disposed/sold 28,828 options to buy
@ $12, valued at
$345.9k
Granted 28,828 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $15.93, valued at
$294.7k
Granted 18,500 options to buy
@ $0
Disposed/sold 1,172 options to buy
@ $15.93, valued at
$18.7k
Granted 1,172 options to buy
@ $0
Disposed/sold 18,500 options to buy
@ $11.49, valued at
$212.6k
Disposed/sold 26,400 options to buy
@ $5.195, valued at
$137.1k
Granted 26,400 options to buy
@ $0 |
|
| 06/02/2023 |
4
| Sanna Bastiano (Director) has filed a Form 4 on Adicet Bio, Inc.|
Txns:
| Granted 5,900 shares
@ $0
Granted 26,400 options to buy
@ $5.195, valued at
$137.1k
|
|
| 05/09/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 422 shares
@ $350.03, valued at
$147.7k
Sold 2,850 shares
@ $350, valued at
$997.5k
|
|
| 05/08/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/05/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/04/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/02/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/06/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 211 shares
@ $314.22, valued at
$66.3k
Sold 94 shares
@ $315.66, valued at
$29.7k
Sold 90 shares
@ $316.76, valued at
$28.5k
Sold 96 shares
@ $317.65, valued at
$30.5k
Sold 31 shares
@ $318.68, valued at
$9.9k
|
|
| 04/04/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 04/04/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,466 shares
@ $313.74, valued at
$459.9k
|
|
| 03/20/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 2,482 shares
@ $300.54, valued at
$745.9k
Sold 264 shares
@ $301.07, valued at
$79.5k
|
|
| 03/16/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 02/28/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,970 shares
@ $289.12, valued at
$1.1M
|
|
| 02/22/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 3,750 shares
@ $292.85, valued at
$1.1M
|
|
| 02/14/2023 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 902 shares
@ $294.33, valued at
$265.5k
Paid exercise price by delivering 4,340 shares
@ $298.26, valued at
$1.3M
Sold 113 shares
@ $300.39, valued at
$33.9k
|
|
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 768 shares
@ $312.84, valued at
$240.3k
Sold 56 shares
@ $310.1, valued at
$17.4k
Sold 39 shares
@ $311.17, valued at
$12.1k
Sold 100 shares
@ $312.4, valued at
$31.2k
Sold 81 shares
@ $313.37, valued at
$25.4k
Sold 12 shares
@ $314.43, valued at
$3.8k
Sold 10 shares
@ $315.68, valued at
$3.2k
Sold 22 shares
@ $317.77, valued at
$7k
|
|
| 10/20/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/03/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 766 shares
@ $276.62, valued at
$211.9k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/04/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 20 shares
@ $255.47, valued at
$5.1k
Sold 90 shares
@ $257.49, valued at
$23.2k
Sold 43 shares
@ $258.46, valued at
$11.1k
Sold 75 shares
@ $259.58, valued at
$19.5k
Sold 23 shares
@ $260.44, valued at
$6k
Sold 65 shares
@ $261.79, valued at
$17k
Sold 4 shares
@ $264.37, valued at
$1.1k
|
|
| 05/03/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 766 shares
@ $276.17, valued at
$211.5k
|
|
| 04/08/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 204 shares
@ $275.71, valued at
$56.2k
Sold 327 shares
@ $276.39, valued at
$90.4k
Sold 30 shares
@ $277.02, valued at
$8.3k
|
|
| 04/06/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Sold 305 shares
@ $267.1, valued at
$81.5k
Sold 257 shares
@ $268.43, valued at
$69k
Sold 3,163 shares
@ $275.23, valued at
$870.6k
|
|
| 04/05/2022 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 1,344 shares
@ $263.09, valued at
$353.6k
|
|
| 03/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/03/2021 |
4
| Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA|
Txns:
| Paid exercise price by delivering 766 shares
@ $185.07, valued at
$141.8k
|
|
|
|
|